UK markets close in 7 hours 37 minutes

ERYTECH Pharma S.A. (0QSS.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.1800-0.0301 (-2.49%)
As of 05:44PM BST. Market open.
Full screen
Previous close1.2101
Open1.1800
Bid0.0000 x 0
Ask0.0000 x 0
Day's range1.1800 - 1.1800
52-week range1.1800 - 1.1800
Volume652
Avg. volumeN/A
Market cap18.303M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.2700
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022

    Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2

  • Globe Newswire

    ERYTECH Provides Business and Financial Update for the First Quarter of 2022

    ERYTECH Provides Business and Financial Update for the First Quarter of 2022 Conference call and webcast on Friday, May 13, 2022at 8:30am EDT / 02:30pm CEST U.S. cell therapy manufacturing facility sold to Catalent for a total consideration of USD 44.5 millionProgress towards seeking approval of GRASPA® (BLA) for the treatment of acute lymphoblastic leukemia (ALL) patients with hypersensitivity to pegylated asparaginase Cash and cash equivalents of EUR 25.1 million (USD 27.9 million) at the end

  • Yahoo Finance Video

    Marriott CEO expects ‘blockbuster summer’ for travel

    Marriott International CEO Anthony Capuano joins Yahoo Finance Live to discuss the hotel chain's latest earnings results, travel demand recovery, and growth amid lingering pandemic concerns.